et al . 4 report two long-term studies assessing the efficacy and tolerance of nemolizumab (a humanized IL-31RA monoclonal antibody) in addition to topical anti-inflammatory agents in adolescent and adult… Click to show full abstract
et al . 4 report two long-term studies assessing the efficacy and tolerance of nemolizumab (a humanized IL-31RA monoclonal antibody) in addition to topical anti-inflammatory agents in adolescent and adult patients with AE. The paper merges the results of the 52-week open extension phase of a previously published 16-week phase III randomized controlled trial (RCT) of nemolizumab vs. placebo (143 and 72 participants, respectively) 5 and an open-label study including 88 participants.
Keywords:
scratch vicious;
vicious circle;
atopic eczema;
targeting itch;
itch scratch;
circle atopic
Journal Title: British Journal of Dermatology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: British Journal of Dermatology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!